Oxywise Medox Private Limited - Due diligence report

A 360° intelligence report on Oxywise Medox Private Limited: trust score, financial health, credit view, compliance, directors, growth and d…

2002-10-13 Vasant Kunj, Delhi Active Unlisted Active Compliant
Share
OM Oxywise Medox Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Oxywise Medox Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
64/100
Trust Score
Moderate

Oxywise Medox Private Limited is assessed as Moderate with a Trust Score of 64/100. Oxywise Medox Private Limited is an active private limited indian non-government company incorporated in 2002, operating in the Home & Lifestyle sector. Reported revenue has declined across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and moderate financial risk profile.

Report generated on 17 Jul 2026 from the latest processed filings. Oxywise Medox Private Limited snapshot & full profile →

Financial Health › Neutral
Overall Assessment CautionWeakNeutralGoodStrong Good
Compliance › Neutral

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
64/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
45/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
50/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
45/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreCaution Indicated
40/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
65/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 45/100 Caution Indicated
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.

Charges position: 0 open (-) · 1 satisfied (80.00 Lakh).

Banking relationships (from registered charges)
LenderChargesAmount
Haryana Financial Corporation1 48.0 cr
Compliance Score: 45/100 Caution Indicated
  • Company status is Active as per MCA.
  • Last balance sheet is for Mar 2023 - filings overdue.
  • Flagged by authority: DRT.
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
ANILKUMAR RAMPRASAD AGARWAL 01234567 Director 01/04/2018 6 yrs Approved
SURBHI ANIL AGRAWAL 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2022 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 40 · Distress 65
Growth signals & trust indicators
Operating for 23+ years.
Distress signals & risk flags
Losses deepening year-on-year.
Statutory filings appear overdue.
Compliance score is weak (45/100).
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence57/100
Review suggested
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 2 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment46/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance gaps should be priced into terms.
Investor view50/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 12 events
30 Sep 2023
Last AGM held
Annual general meeting
31 Mar 2023
Latest balance sheet
Filed with ROC
29 Sep 2018
Director ceased
ANIRUDDH ANILKUMAR AGRAWAL
Director ceased
DINDAYAKAR PRASAD
Director ceased
VIJAY KUMAR GUPTA
02 Sep 2009
Charge satisfied
Haryana Financial Corporation
30 Apr 2009
Director ceased
VIJAY YADAV
Director ceased
BABITA YADAV
03 Jan 2009
Director appointed
ANILKUMAR RAMPRASAD AGARWAL (Director)
Director appointed
SURBHI ANIL AGRAWAL (Director)
24 Feb 2006
Charge created
Haryana Financial Corporation - 80.00 Lakh
13 Oct 2002
Incorporated
Registered with Roc Delhi
10

Key Observations

Auto-generated from the data above
Revenue declined 38% over the last 4 financial year(s).
Net profit margin moved from 1.42 to 2.1x.
Net worth is positive.
2 active director(s) / partner(s); board looks stable and experienced.
All 1 registered charge(s) stand satisfied - past borrowings repaid.
Promoters hold a dominant controlling stake as per the FY 2022 annual return.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Transecute Solutions Private Limited U72900MH2009PTC194583 Mumbai, Maharashtra, India
Events Technologies India Private Limited U72200PN1999PTC013904 Daund, Maharashtra, India
Facio Communications Private Limited U74999DL2014PTC271088 New Delhi, Delhi, India
Arovent Technologies Private Limited U74999DL2018PTC329720 Delhi, Delhi, India
Rapidmind Technologies Private Limited U74999KA2018PTC109655 Bangalore, Karnataka, India
Risingranges Technology Development Private Limited U72900CT2020PTC010228 Ambikapur, Chattisgarh, India
Firezeal Internet Solutions Private Limited U74999TG2018PTC126055 Seri Lingampally, Telangana, India
Knowlexon Innovation And Technology Private Limited U74999PN2017PTC170642 Pune, Maharashtra, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Oxywise Medox Private Limited before audits and certifications: compliance score 45/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Oxywise Medox Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 45/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 40/100, margin trends, ownership structure and peer set for Oxywise Medox Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Review suggested. Trust score 64/100, distress signals and MSME payment-delay disclosures - know whether Oxywise Medox Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Oxywise Medox Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Oxywise Medox Private Limited an active company?

Oxywise Medox Private Limited has MCA status “Active” with a compliance score of 45/100 (Caution Indicated).

Is Oxywise Medox Private Limited financially healthy?

Oxywise Medox Private Limited has a Financial Health Score of 50/100 (Moderate) based on its filed financial statements.

Should I do business with Oxywise Medox Private Limited?

Its overall Trust Score is 64/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Oxywise Medox Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 2 active director(s) are on record.

Does Oxywise Medox Private Limited have loans or charges against its assets?

No open charges - all 1 registered charge(s) stand satisfied, indicating past borrowings were repaid.

Is Oxywise Medox Private Limited up to date with its ROC filings?

Last balance sheet is for Mar 2023 - filings overdue. Overall compliance score: 45/100 (Caution Indicated).

Is it risky to lend to Oxywise Medox Private Limited?

Its Credit Risk Score is 45/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.